Biotech

All Articles

Analysts dig into Avidity's DMD succeed, revealing subtleties in data

.Avidity Biosciences impressed financiers with period 1/2 data in Duchenne muscular dystrophy (DMD) ...

Actinogen's cortisol blocker falls short stage 2 anxiety study

.Actinogen Medical's cortisol blocker has skipped the major endpoint of a period 2 research in depre...

Bivictrix chooses going exclusive only technique to take ADC in to facility

.Antibody-drug conjugates (ADCs) have actually been at the center of numerous a billion-dollar biobu...

TPG bests up funds to $580M for expenditures across lifestyle scientific researches

.Possession manager TPG, which has assisted biotechs such as Sionna Rehabs and Santa Clam Ana Bio, h...

Merck stops stage 3 TIGIT trial in lung cancer for futility

.Merck &amp Co.'s TIGIT program has actually gone through one more setback. Months after shuttering ...

After a hard year, Exscientia folds up in to Recursion

.After a year determined through pipeline hairstyles, the variation of its CEO and layoffs, Exscient...

Cullinan, after $25M package, restore bispecific to Harbour

.Cullinan Rehab was actually impressed sufficient along with Harbour BioMed's bispecific immune syst...

A nearer consider Strong Biotech's Brutal 15

.In this particular week's incident of "The Leading Line," our company're diving right into Fierce B...

Lilly encounters stage 2 failing of tau-targeting med

.The confetti is still flying coming from Eli Lilly's event commemorating the approval of Alzheimer'...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings a...